In conclusion, we identified for the first time that a higher expression of SHIP2 in CRC tissues compared to the noncancerous tissues and SHIP2 might play an essential role as a prognostic marker of survival in patients with CRC. The gene discussed is INPPL1; the disease is colorectal carcinoma.